He is also technical advisor and member of scientific advisory committees for the World Health Organization (WHO), the Global Access for the Global Antibiotic Research and Development Partnership (GARDP) and for Vivli’s antimicrobial resistance (AMR) Register. In his work to mitigate AMR, Marc considers clinical, research and policy perspectives.
Marc studied Medicine at St Mary’s Hospital, London and specialised in Infectious Diseases at Addenbrookes Hospital, Cambridge, where he attained his PhD. He moved to The Rockefeller University, New York in 2001 and subsequently to UCT to work on tuberculosis and innate immunity.